2.6.1.45	(NH4)2SO4	0.05 mM, 45% inhibition, 5 mM, complete inhibition	399	
2.6.1.45	2-oxoglutarate	2-oxoglutarate at a concentration above 12.5 mM inhibits enzyme SgaBath in the serine-2-oxoglutarate aminotransferase (SKAT) reaction, but has no effect on the serine-glyoxylate aminotranferase (SGAT) reaction, substrate inhibition	34	
2.6.1.45	2-oxoglutarate	2-oxoglutarate at a concentration above 12.5 mM inhibits enzyme Sga20Z in the serine-2-oxoglutarate aminotransferase (SKAT) reaction, but has no effect on the serine-glyoxylate aminotranferase (SGAT) reaction, substrate inhibition	34	
2.6.1.45	3-chloro-L-alanine	-	3967	
2.6.1.45	AgNO3	strong inhibition	360	
2.6.1.45	Aminooxyacetate	1 mM, complete inhibition	1374	
2.6.1.45	Aminooxyacetate	competitive inhibition	1374	
2.6.1.45	Aminooxyacetate	reacts with the carbonyl group of pyridoxal phosphate, 88% inhibition at 0.01 mM	1374	
2.6.1.45	ammonium acetate	0.1 mM, 42% inhibition, 10 mM, complete inhibition	9097	
2.6.1.45	beta-chloro-L-alanine	reacts with the carbonyl group of pyridoxal phosphate. 53.9% inhibition at 1 mM	1641	
2.6.1.45	beta-chloroalanine	competitive vs. L-alanine, uncompetitive vs. 2-oxomalonate	5134	
2.6.1.45	cycloserine	weak inhibition	2837	
2.6.1.45	D-serine	competitive inhibition	481	
2.6.1.45	D-serine	competitive inhibition with L-serine	481	
2.6.1.45	formaldehyde	glyoxylate protects	130	
2.6.1.45	glycine	competitive vs. L-serine	72	
2.6.1.45	glyoxylate	competitive vs. pyruvate	101	
2.6.1.45	glyoxylate	irreversible inhibition only in the presence of NH4+, inactivation in the absence of amino acid substrates	101	
2.6.1.45	glyoxylate	amino acid substrates partially protect	101	
2.6.1.45	glyoxylate	presence of D-serine protects against inhibition	101	
2.6.1.45	glyoxylate	inhibited by glyoxylate above 6 mM	101	
2.6.1.45	HgCl2	strong inhibition	110	
2.6.1.45	hydroxylamine	0.01 mM, 98% inhibition of serine-glyoxylate transamination	85	
2.6.1.45	hydroxylamine	0.01 mM, 85% inhibition of glycin-hydroxypyruvate transamination	85	
2.6.1.45	hydroxylamine	0.1 mM, 97% inhibition, 85% inhibition in the presence of 0.1 mM pyridoxal phosphate	85	
2.6.1.45	hydroxylamine	0.002 mM, 92% inhibition, serine, L-alanine and glycine protect	85	
2.6.1.45	hydroxylamine	-	85	
2.6.1.45	hydroxylamine	0.1 mM, 70% inhibition	85	
2.6.1.45	iodoacetamide	-	67	
2.6.1.45	Isonicotinic acid hydrazide	0.1 mM, 20% inhibition	2409	
2.6.1.45	KCN	weak inhibition	161	
2.6.1.45	L-alanine	competitive vs. L-serine	103	
2.6.1.45	L-asparagine	competitive vs. serine	266	
2.6.1.45	L-serine	competitive vs. asparagine	95	
2.6.1.45	MgCl2	weak inhibition	196	
2.6.1.45	additional information	not inhibited with or without NH4+ by oxalate, formate, acetaldehyde, pyruvate, hydroxypyruvate, 2-oxoglutarate	2	
2.6.1.45	additional information	not inhibited by NaBH4, 3-chloro-D-alanine, 1,10-phenanthroline, 2,2'-dipyridyl, 8-hydroxyquinoline, EDTA, iodoacetate, FeCl3, AlCl3, CdCl2, CoCl2, NiCl2, CaCl2, NaN3, ZnCl2, PbCl2, LiCl, CuCl2, BaCl2, ascorbate, cysteamine, N-ethylmaleimide	2	
2.6.1.45	additional information	not inhibited by 5,5'-dithio-bis(2-nitrobenzoate)	2	
2.6.1.45	N-ethylmaleimide	1 mM, 41% inhibition	49	
2.6.1.45	N-ethylmaleimide	-	49	
2.6.1.45	N-ethylmaleimide	weak, but significant inhibition	49	
2.6.1.45	NaF	weak inhibition	235	
2.6.1.45	NH4+	reversible inhibition	54	
2.6.1.45	NH4+	-	54	
2.6.1.45	NH4Cl	0.1 mM, 42% inhibition, 10 mM, complete inhibition	329	
2.6.1.45	NH4Cl	glycine-hydroxypyruvate transamination is only weakly inhibited	329	
2.6.1.45	NH4Cl	competitive vs. L-serine	329	
2.6.1.45	oxalate	competitive vs. 2-oxomalonate, uncompetitive vs. L-serine	185	
2.6.1.45	p-chloromercuribenzoate	1 mM, 37% inhibition	43	
2.6.1.45	p-chloromercuribenzoate	-	43	
2.6.1.45	p-hydroxymercuribenzoate	-	98	
2.6.1.45	p-hydroxymercuribenzoate	weak but significant inhibition	98	
2.6.1.45	p-hydroxymercuribenzoate	the 24.1% decrease in enzyme activity achieved using 1.0 mM inhibitor might be considered to be unspecific	98	
2.6.1.45	Penicillamine	weak inhibition	2496	
2.6.1.45	phenylhydrazine	weak inhibition	398	
2.6.1.45	pyruvate	competitive vs. glyoxylate	31	
2.6.1.45	Semicarbazide	-	382	
2.6.1.45	SH-group inhibitor	-	114430